Qian Chu
Clinical trials sponsored by Qian Chu, explained in plain language.
-
New hope for aggressive lung cancer: adding immunotherapy to standard treatment
Disease control Recruiting nowThis study is testing whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can better control limited-stage small cell lung cancer. The trial will enroll 100 adults with this aggressive cancer who haven't had previous treatment. Researchers want…
Phase: PHASE2 • Sponsor: Qian Chu • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can computers predict your cancer treatment success?
Knowledge-focused Recruiting nowThis study aims to develop a tool that can predict how well patients with non-small cell lung cancer will respond to treatment before surgery. Researchers will collect various types of data from 500 patients receiving chemo-immunotherapy followed by surgery. The goal is to create…
Sponsor: Qian Chu • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC